HMGB1 and breast cancer: Chang et al. have shown that miR-200c inhibits EMT and metastasis of breast cancer cells by targeting HMGB1 [31], and Jiao et al. have reported that miR-200c inhibits the metastasis of A549 cells by targeting ZEB2, an EMT regulator [32].